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A 76-year-old man was admitted in April 1997 with a 6-week
history of sweats, lethargy, anorexia and weight loss of 8 kg.
The patient had been treated with antibiotics for left-sided
orchitis 4 weeks before admission. Past history included rheu-
matic fever when aged 17, bacterial endocarditis (1973), mitral
valvuloplasty (1974) and a permanent pacemaker insertion
(1986).
Following admission, the patient became pyrexial (38.4 °C).
On auscultation, a pansystolic and mid-diastolic murmur were
audible at the apex, but with no peripheral stigmata of endo-
carditis. On admission, C-reactive protein (CRP) was
205 mg/L (‘normal’ range 0–10 mg/L), hemoglobin 107 g/L
(‘normal’ range 130–180 g/L), white cell count 8.7  109/L
(‘normal’ range 4–10  109/L) and platelets 240  109/L
(‘normal’ range 150–450  109/L). Transoesophageal echo-
cardiography (TOE) showed a calcified mitral valve with a
vegetation on the posterior leaflet. No vegetations were seen
on the pacemaker wire. Multiple blood cultures performed
before antibiotic treatment were all negative, as were serological
tests for Brucella spp., Coxiella burnetii, Chlamydia spp. and
Legionella spp. Using Duke’s classification, the patient was cat-
egorized into the ‘definite diagnosis category’ for infective
endocarditis [1].
The patient was commenced on intravenous imipenem
(500 mg every 6 h) and netilmicin (350 mg once daily). After
treatment for 15 days, the CRP fell to 95 mg/L but, although
symptomatically improved, the patient remained febrile
(37.5 °C). After further blood cultures were taken, antibiotics
were changed to intravenous teicoplanin (400 mg once daily)
and ciprofloxacin (500 mg twice daily). This regimen was con-
tinued for a further 28 days, during which the CRP fell to
65 mg/L, but the patient’s temperature failed to settle. Conse-
quently all intravenous antibiotics were discontinued and, after
hospitalization for 63 days, the patient was discharged home for
out-patient follow-up.
On review after 3 weeks, the patient remained pyrexial
(37.5 °C) and the CRP was elevated to 108 mg/L. The patient
was re-admitted for further investigation and treatment. Blood
cultures were performed and serology repeated, all of which
were negative. The patient was commenced on intravenous
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teicoplanin (400 mg once daily) and oral rifampicin (600 mg
once daily) but, after 13 days, remained pyrexial (37.7 °C)
and with a CRP of 115 mg/L. All antibiotic treatment was
discontinued and, for the next 3 weeks, the patient improved
symptomatically, his temperature settled, and the CRP fell to
46 mg/L. Repeat TOE showed no resolution of the vegetation.
The patient was discharged after 33 days and, on review, his
CRP fell to 1 mg/L.
Retrospectively, 13 of 27 sets of the patient’s blood cultures,
encompassing both admissions, were examined with molecular
nucleic acid-based amplification techniques. Traditionally,
microbiological diagnosis of endocarditis has been based on
positive blood cultures or serology (e.g. Q fever) but the
expanding use of rRNA methodologies now offers an
additional approach.
The 16S and 28S rRNA genes are found in bacteria and
fungi, respectively. In this study, universal primers were used
that are specific for these genes, with hypervariable regions
amplified using the polymerase chain reaction (PCR) [2,3].
Experiments were performed in a blind randomized fashion,
with appropriate negative and positive controls. Amplicons
resulting from amplification of the 16S rRNA gene were
observed in 12 of 13 blood culture sets, but no 28S rRNA was
detected, thereby indicating the presence of bacterial DNA
and the absence of fungal DNA, respectively. The 16S rRNA
amplicon corresponded to a 216 bp sequence containing two
highly conserved regions, namely, the primer sites [2], and one
hypervariable region, which was sequenced in an attempt to
identify the bacterial agent. Amplicons were purified using a
QIAquick PCR purification Kit (Qiagen, Crawley, UK) prior
to sequencing to remove dNTPs, polymerases, salts and
primers. Purified amplicons were sequenced in an ABI
PRISMTM dye terminator cycle sequencing reaction with
AmpliTaq® DNA polymerase and the forward 16S rRNA
primer [2], according to the manufacturer’s instructions (PE
Applied Biosystems, Warrington, UK), followed by analysis on
a 24 cm well-to-read gel (ABI 373; PE Applied Biosystems).
Sequence data were compared with known 16S rRNA
sequences deposited in the EMBL and GenBank nucleotide
databases using BLAST alignment software. Sequence analysis
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Figure 1 C-reactive protein (CRP) measurements observed following antibiotic treatment during (a) first admission period and (b) second
admission period.
identified the organism as an Acinetobacter sp. (100% homology
with accession number X86572; 99.03% homology with Mor-
axella S2–11 16S rRNA, accession number X86616). The
region amplified was highly conserved with all Acinetobacter spp.
and it was therefore not possible to identify the amplicon to
species level.
Infective endocarditis caused by Acinetobacter spp., although
rare, has been reported previously in both native and prosthetic
valves [4] and several aspects of this case support the molecular
diagnosis. Using CRP as an indicator of treatment response,
the greatest fall was seen with imipenem and netilmicin (Figure
1a), i.e. antibiotics which would be expected to have good
activity against Acinetobacter spp. When treatment was changed
to teicoplanin and ciprofloxacin the CRP, although failing to
sustain the same rate of decline, fell from 95 to 65 mg/L (Figure
1a). During the second admission period, treatment with teico-
planin and rifampicin, a combination which might be expected
to have little if any efficacy for Acinetobacter endocarditis,
resulted in no CRP response (Figure 1b).
The incidence of culture-negative endocarditis (CNE) varies
between 2.5 and 31% [5] and poses particular problems for the
physician in relation to appropriate treatment and increased
morbidity. Over recent years, molecular-based techniques have
been used, with some success, to aid in the diagnosis of CNE,
particularly for cases of endocarditis caused by Bartonella spp.
[6]. and Coxiella burnetii [7]. More recently, a molecular
approach has been used to detect bacterial agents in excised
heart valve material from endocarditis patients [8]. Identifying
causative agents directly from blood culture material enables
appropriate antimicrobial therapy to be commenced earlier in
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the course of the disease, reducing the need for valve replace-
ment and improving patient outcome.
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